Back to Search
Start Over
Adverse Effects of Oxidative Stress on Bone and Vasculature in Corticosteroid-Associated Osteonecrosis: Potential Role of Nuclear Factor Erythroid 2-Related Factor 2 in Cytoprotection.
- Source :
-
Antioxidants & redox signaling [Antioxid Redox Signal] 2021 Aug 10; Vol. 35 (5), pp. 357-376. Date of Electronic Publication: 2021 Apr 05. - Publication Year :
- 2021
-
Abstract
- Significance: Osteonecrosis (ON) is characterized by bone tissue death due to disturbance of the nutrient artery. The detailed process leading to the necrotic changes has not been fully elucidated. Clinically, high-dose corticosteroid therapy is one of the main culprits behind osteonecrosis of the femoral head (ONFH). Recent Advances: Numerous studies have proposed that such ischemia concerns various intravascular mechanisms. Of all reported risk factors, the involvement of oxidative stress in the irreversible damage suffered by bone-related and vascular endothelial cells during ischemia simply cannot be overlooked. Several articles also have sought to elucidate oxidative stress in relation to ON using animal models or in vitro cell cultures. Critical Issues: However, as far as we know, antioxidant monotherapy has still not succeeded in preventing ONFH in humans. To provide this desideratum, we herein summarize the current knowledge about the influence of oxidative stress on ON, together with data about the preventive effects of administering antioxidants in corticosteroid-induced ON animal models. Moreover, oxidative stress is counteracted by nuclear factor erythroid 2-related factor 2 (Nrf2)-dependent cytoprotective network through regulating antioxidant expressions. Therefore, we also describe Nrf2 regulation and highlight its role in the pathology of ON. Future Directions: This is a review of all available literature to date aimed at developing a deeper understanding of the pathological mechanism behind ON from the perspective of oxidative stress. It may be hoped that this synthesis will spark the development of a prophylactic strategy to benefit corticosteroid-associated ONFH patients. Antioxid. Redox Signal. 35, 357-376.
- Subjects :
- Bone and Bones metabolism
Cardiovascular System metabolism
Humans
Osteonecrosis metabolism
Oxidative Stress drug effects
Adrenal Cortex Hormones pharmacology
Antioxidants pharmacology
Bone and Bones drug effects
Cardiovascular System drug effects
NF-E2-Related Factor 2 metabolism
Osteonecrosis diet therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1557-7716
- Volume :
- 35
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Antioxidants & redox signaling
- Publication Type :
- Academic Journal
- Accession number :
- 33678001
- Full Text :
- https://doi.org/10.1089/ars.2020.8163